期刊文献+

关于原发性醛固酮增多症诊治的常见误区

Misunderstandings in the diagnosis and treatment of primary aldosteronism
原文传递
导出
摘要 原发性醛固酮增多症(primary aldosteronism,PA)是最常见的继发性高血压之一。与原发性高血压患者相比,P A患者的心脑血管疾病和死亡风险更高,因此早期诊断、早期治疗至关重要。虽然国内外对PA的研究取得了巨大的进步,但其漏诊率、误诊率仍然很高。目前我国关于PA的诊治仍存在不少误区,导致部分PA患者未得到及时、准确的诊治。本文将根据国内外相关研究报道以及自身的临床体会就P A诊治的关键问题及误区进行讨论。 Primary aldosteronism(PA)is one of the most common secondary hypertension.Compared with patients with primary hypertension,patients with PA have a higher risk of cardiovascular diseases and death,so early diagnosis and early treatment are crucial.Although great progress on PA research has been made both at home and abroad,the rate of its misdiagnosis is still very high.At present,there are still many misunderstandings about PA in China,leading some PA patients not receiving timely and accurate diagnosis and treatment.Based on recent researches at home and abroad and our clinical experience,this article discusses some key points and misunderstandings with regards to the diagnosis and treatment of PA.
作者 郑爱琳 宋颖 罗蓉 李启富 Zheng Ailin;Song Ying;Luo Rong;Li Qifu(Health Management Center,The First Affiliated Hospital of Chongqing Medical University,Chongqing 400010,China;Department of Endocrinology,The First Affiliated Hospital of Chongqing Medical University,Chongqing 400010,China)
出处 《国际内分泌代谢杂志》 2021年第2期73-77,共5页 International Journal of Endocrinology and Metabolism
关键词 原发性醛固酮增多症 醛固酮 肾素 误区 Primary aldosteronism Aldosterone Renin Misunderstanding
  • 相关文献

参考文献3

二级参考文献26

  • 1曾正陪.内分泌性高血压的现状及诊治[J].临床内科杂志,2006,23(3):149-152. 被引量:18
  • 2Hafner S, Baumert J, Emeny RT, et al. Hypertension and de- pressed symptom - atology : a cluster related to the activation of the renin - angiotensin - aldosteronesystem ( RAAS ). Findings from population based KORA F4 study[J]. Psycho -neuroendocrinolo- gy, 2013, 38(10): 2065-2074.
  • 3Born - Frontsberg E, Reincke M, Rump LC, et al. Cardiovascular and cerebrovascula comorbidities of hypokalemic and normokalemic primary aldosteronism ; results of the German Conn' s registry[ J]. J Clin Endoerinol Metab, 2009, 94(4) : 1125 -1130.
  • 4Schut AF, Bleumink GS, Stricker BH, et al. Angiotensin coverting enzyme insertion/deletion polymorphism and the risk of heart failure in hypertensive subjects[J]. Eur Heart J, 2004, 25(23) : 2143 - 2148.
  • 5Kofodziejczyk - Kruk S, Januszewicz W, P6czkowska M, et al. Pri- mary aldosteronism - recent progress and current concepts [ J ]. En- dokrynol Pol, 2013, 64(4) : 312 -318.
  • 6Corbin F, Douville P, Lebel M. Active renin mass concentration todetermine aldosterone - to - renin ratio in screening for primary al- dosteronism[ J]. Int J Nephrol Renovasc Dis, 2011, 4( 1 ) : 115 - 120.
  • 7Pilz S, Kienreich K, Gaksch M, et al. Aldosterone to active Renin ratio as screening test for primary aldosteronism:reproducibility and influence of orthostasis and salt loading [ J ]. Horm Metab Res, 2014, 46(6) : 427 -432.
  • 8Jenny M, Evelyn F, Anna D, et al. Clinical validation for the aldo- sterone - to - renin ratio and aldosterone suppression testing using simultaneous fully antomated chemiluminescence immunoassays [J]. JHypert, 2015, 33(1): 1 -12.
  • 9Michel A, Joel M. Measurement of plasma renin: a critical review of methodology[ J]. J Renin Angiotensin Aldostemne Syst, 2010, 11(2): 89-90.
  • 10Funder JW, Careyr M, Fardellac M, et al. Case detection, diagno- sis and treatment of patients with primary aldosteronism: an endo- crine society clinical practice guideline [ J ]. J Clin Endocrinol Metab, 2008, 93(9): 266-281.

共引文献178

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部